Exploring new ways to improve prostate cancer treatment and outcomes.
Official title: Developmental Research Program
Funded at University of Wisconsin-Madison · NIH-10899416 · Data updated 2026-11-12
This study is exploring new ways to better understand and treat prostate cancer, so that patients can benefit from improved care and potentially live longer, healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $127,825 |
| NIH project number | 5P50CA269011-02 |
| Project ID | NIH-10899416 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with prostate cancer, particularly those interested in participating in innovative treatment approaches.
✕Less likely to help
Patients with non-prostate cancers or those not diagnosed with cancer may not receive any benefit from this research.
What this research studies
The Developmental Research Program at the University of Wisconsin focuses on innovative early-phase projects aimed at enhancing the understanding and treatment of prostate cancer. This program supports research in areas such as prevention, early detection, and the development of biomarkers that can predict disease outcomes. By fostering collaboration among researchers from various disciplines, the program aims to generate impactful findings that can lead to new clinical trials and treatment strategies. Patients may benefit from advancements in care and improved survival rates as a result of this research.
Why it matters
Potential benefit: If successful, this research could lead to significant improvements in the diagnosis and treatment of prostate cancer, ultimately reducing patient morbidity and mortality.
How similar studies have gone: Previous research in similar developmental programs has shown promise in advancing cancer treatment and outcomes, indicating a strong potential for success in this initiative.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Liu, Glenn — University of Wisconsin-Madison
- Study coordinator: Liu, Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.